Skip to main content
CRBU logo

CRBU · Caribou Biosciences, Inc. · Executive Compensation

Track CRBU — free
$1.27 -0.10 (-7.30%) At close · Sep 11
Market Cap
$136.15M
Shares
107.21M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Rachel Haurwitz $1,840,965
Sriram Ryali $1,029,413
Barbara McClung $919,574
Fiscal 2024
Executive Total
Rachel Haurwitz $4,213,245
Tim Kelly $1,913,370
Barbara McClung $1,612,819
Steven Kanner $1,612,819
Fiscal 2023
Executive Total
Rachel Haurwitz $3,116,547
Syed Rizvi $1,268,277
Barbara McClung $1,217,807
Steven Kanner $1,217,807
Fiscal 2022
Executive Total
Syed Rizvi $2,388,492
Ruhi Khan $1,038,077
Rachel Haurwitz $833,468
Fiscal 2021
Executive Total
Rachel Haurwitz $6,249,919
Jason O’Byrne $3,449,030
Barbara McClung $2,743,054
Fiscal 2020
Executive Total
Rachel Haurwitz $663,900
Barbara McClung $504,150
Jason O’Byrne

Executive changes

Person Change Filed
Ryan Fischesser Terminated 2025-01-02
Sriram Ryali Appointed 2025-01-02
Ryan Fischesser Appointed 2024-09-03
Jason O'Byrne Resigned 2024-09-03
Key facts CIK 1619856 CUSIP 142038108 13F (30d) 4 filings 4 filers Visit website Investor relations